Star Cements Ltd is engaged in manufacturing and selling of Cement Clinker & Cement. It sells its products across north-eastern and eastern states in India. It is the largest cement manufacturer in North-east India.
The company possesses a cost and scale advantage in the Northeast region of India, supported by a dominant market share and proximity to limestone reserves. This is corroborated by high EBITDA margins per ton and a significant pricing premium over competitors in its core geography.
The company has a track record of reinvesting earnings into capacity expansions (Guwahati, Silchar, and Rajasthan) while maintaining a very low debt-to-equity ratio. Capital is deployed toward integrated units and logistics infrastructure to protect margins.
The investment collapsed as the company's regional dominance in the Northeast was dismantled by aggressive pan-India competitors who neutralized Star's logistics advantage through superior scale. While management chased growth in Rajasthan, the core Meghalaya operations were crippled by escalating local unrest and labor strikes, turning a once-efficient supply chain into a cost center. The capital-intensive expansion into new geographies failed to replicate the high EBITDA margins of the home turf, and the 15-crore political donation signaled a shift toward rent-seeking behavior that preceded a permanent decline in return on capital.
RichFakir rates Star Cement Ltd's business quality as decent — 64/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as narrow.
On our model, Star Cement Ltd is trading about 64% above our estimate of fair value; we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Star Cement Ltd is: Watch — wait for price. A decent business, but at an expensive price against our estimate of fair value — one to keep on the watchlist for a better entry.
RichFakir's educational estimate of Star Cement Ltd's fair value is about ₹105 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →